Rimon Golovey

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a64720b0-f4e9-11ed-b68f-a56b34798745.jpg

First Name

Rimon

Last Name

Golovey

NPI

1225666993

Faculty ID

17585

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

123893

Visit Type ID

2541

Is Open Scheduling

On

Michele H. Mokrzycki

https://assets.montefioreeinstein.org/profiles/images/physphoto/Mokrzycki_Michele_MD-2.jpg

First Name

Michele

Last Name

Mokrzycki

NPI

1215048822

Faculty ID

4647

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Mokrzycki&nbsp;is a graduate of&nbsp;Boston College (B.S., 1983),&nbsp;and the University of Vermont College of Medicine (M.D., 1987) and received a&nbsp;Masters&nbsp;of Science&nbsp;in Clinical Research from the Albert Einstein College of Medicine (M.S. 2000). She&nbsp;completed&nbsp;both an&nbsp;Internal&nbsp;Medicine Residency and Clinical Nephrology Fellowship at the University&nbsp;of&nbsp;Connecticut Health Science Center in Farmington, CT. &nbsp;Dr Mokrzycki has been on faculty at the Albert Einstein College of Medicine since 1992, where she is a Professor of Medicine in the Division of Nephrology. &nbsp;She is a full time clinical nephrologist at the Montefiore Medical Center, Moses Campus.</p>
<p>Dr Mokrzycki's&nbsp;research interests have focused primarily on hemodialysis vascular access related complications, specifically,&nbsp;complications associated with tunneled catheter use such as infection/bacteremia/inflammation and dysfunction/thrombosis. &nbsp;</p>
<p>She is the recipient of a grant from the AETNA Foundation to study the effect of a multidisciplinary team approach to improve outcomes associated with catheter bacteremia in hemodialysis patients. &nbsp;</p>
<p>Dr Mokrzycki&nbsp;served on the Program Committee Member for the National Kidney Foundation (NKF)&nbsp;for 2 years, and on Faculty for the Therapeutic Apheresis Academy (TAA)&nbsp;for&nbsp;5 years, which is&nbsp;held annually at the University of Virginia College of Medicine. She has been an invited speaker and/or chaired sessions&nbsp;at the American Society of Nephrology (ASN),&nbsp;National Kidney Foundation (NKF), the Vascular Access Society (VAS), Hemodialysis University (HDU), Annual Dialysis Conference (ADC), the&nbsp;American Society of Diagnostic and Interventional Nephrology (ASDIN), and the VEITH symposium.</p>
<p>Dr Mokrzycki served on the Catheter Endpoints Workgroup of the Kidney Health Initiative (KHI), formed by the American Society of Nephrology,the FDA and other stakeholders in End Stage Kidney Disease Innovation. &nbsp;Dr Mokrzycki currently serves as the Chair of the Vascular Accesss Outcomes Workgroup, a subgroup of the Nephrologists Transforming Dialysis Safety Initiative (NTDS), which is a collaboration between the American Society of Nephrology and the Centers for Disease Control.&nbsp;</p>
<p>&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Dr. Mokrzycki is board certified in Nephrology and is a Fellow of the American Society of Nephrology. Clinical interests include Glomerular Diseases, Acute and Chronic Kidney Diseases, Hypertension, Kidney Stones, Renal Cystic Diseases, Dialysis, and Vascular Access for Hemodialysis.</p>

Research Focus

<p>Dr. Mokrzycki completed a Masters Program in Clinical Research at the Albert Einstein College of Medicine. The author of over 50 peer-reviewed publications, Dr. Mokrzycki&rsquo;s research focuses on reducing hemodialysis vascular access infectious and thrombotic complications.</p>

Elsevier Profile

Selected Publications

<ol>
<li><strong>Mokrzycki MH</strong>, Yamase H, Kohn OF.&nbsp; Renal malacoplakia with papillary necrosis and renal failure. Am J Kidney Dis 19:587-91, 1992.</li>
<li><strong>Mokrzycki MH</strong>, Kaplan AA.&nbsp; Therapeutic Plasma Exchange: Complications and management.&nbsp; Am J Kidney Dis 23:817-27, 1994.</li>
<li><strong>Mokrzycki MH</strong>, Rickles F, Kaplan AA, Kohn OF.&nbsp; Thrombotic thrombocytopenic purpura in pregnancy: Successful treatment with plasma exchange.&nbsp; Blood Purif 13:271-82, 1995.</li>
<li>Posner L, <strong>Mokrzycki MH</strong>. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.&nbsp; Am J Nephrol 16:339-43,1996.</li>
<li>Kerr A, Spector J, <strong>Mokrzycki MH</strong>, Blau S, Simon R.&nbsp; V asodilator provocation of occult urinar y tract hemorrhage. J Trauma 40:152-4, 1996.</li>
<li><strong>Mokrzycki MH</strong><span style="text-decoration: underline;">,</span> Kaplan AA.&nbsp; Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 7:1-5, 1996.</li>
<li><strong>Mokrzycki MH</strong><span style="text-decoration: underline;">,</span> Harris C, May H, Laut J, Palmisano J.&nbsp; Lactic acidosis associated with stavudine (d4T): Report of 5 cases. Clin Inf Dis 30:198-200, 2000.</li>
<li><strong>Mokrzycki MH</strong>, Schroppel B, von Gersdorff G, Rush H, Zdunek M, Feingold R.&nbsp; Tunneled cuffed catheter associated infections in hemodialysis patients seropositive for the human immunodeficiency virus.&nbsp; J Am Soc Nephrol 11:2122-2127, 2000.</li>
<li>Barisoni L, <strong>Mokrzycki MH</strong>, Sablay L, Nagata M, Yamase H, Mundel P.&nbsp; Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.&nbsp; Kidney Int 58:137-143, 2000.</li>
<li>Zdunek MP, Mitra A, <strong>Mokrzycki MH</strong>.&nbsp; Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: Timing is important for maximizing clearance.&nbsp; Am J Kidney Dis 36:177-183, 2000.</li>
<li>Solomon N, <strong>Mokrzycki MH</strong>.&nbsp; Levofloxacin-associated allergic interstitial nephritis.&nbsp; Clin Nephrol 54:356, 2000.</li>
<li><strong>Mokrzycki MH</strong>, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO.&nbsp; A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 59:1935-1942, 2001.</li>
<li>Swiatecka-Urban A, <strong>Mokrzycki MH</strong>, Kaskel F, Da Silva F, Denamur E.&nbsp; Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.&nbsp;&nbsp; Pediatr Nephrol 16:627-630, 2001.</li>
<li><strong>Mokrzycki MH,</strong> Singhal A.&nbsp; Cost-Effectiveness of Three Strategies of Managing Tunneled-Cuffed Hemodialysis Catheters (TCC) in Clinically Mild or Asymptomatic Bacteremias.&nbsp; Nephrol Dial Transpl 17(12): 2196-203, 2002.</li>
<li>Negulescu O, Coco M, Croll J, <strong>Mokrzycki MH</strong>. Large atrial thrombus formation associated with tunneled cuffed hemodialysis catheters. Clin Nephrol 59(1):40-6, 2003.</li>
<li>Golestaneh L, Laut J, Rosenberg S, Zhang M, <strong>Mokrzycki MH</strong>.&nbsp; Favourable outcomes in episodes of Pseudomonas bacteremia when associated with tunneled cuffed catheters (TCC) in chronic hemodialysis patients.&nbsp; Nephrol Dial Transplant. May;21(5):1328-33,2006.</li>
<li><strong>Mokrzycki MH</strong>, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO.&nbsp; Tunneled Hemodialysis Catheter Bacteremia: Risk factors for bacteremia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 21(4):1024-31,2006.</li>
<li><strong>Mokrzycki MH</strong>, Zhang M, Golestaneh L, Laut J, Rosenberg SO.A randomized controlled trial comparing two management models for the treatment of tunneled cuffed catheter (TCC) bacteremia: A collaborative team model versus usual physician-managed care. Am J Kidney Dis 48(4):587-95, 2006.</li>
<li>McKenzie LM, Hendrickson, SL, Briggs WA, Dart RA, Korbet SM, <strong>Mokrzycki MH</strong>, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA.&nbsp; NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol 18(11): 2987-95, 2007</li>
<li><strong>Mokrzycki MH.</strong>&nbsp; Use of prophylactic topical or intraluminal antibiotics for hemodialysis catheters. Nat Clin Pract Nephrol 4(9):478-9, 2008.</li>
<li>Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, <strong>Mokrzycki MH</strong>, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 40 (10):1175-84, 2008.</li>
<li>Sachdeva M, Bitzer M, <strong>Mokrzycki MH</strong>. Vascular access type and changes in inflammatory markers in incident dialysis patients: a pilot study.&nbsp; J Vascular Access 10(3):174-179, 2009.</li>
<li>Golestaneh L, Gofran A, <strong>Mokrzycki MH</strong>, Chen JL.&nbsp; Removal of vancomycin in sustained low-efficiency dialysis (SLED): a need for better surveillance and dosing.&nbsp; Clin Neph 72 (4):286-291.</li>
<li>Okafor C, Ward DM, <strong>Mokrzycki MH,</strong> Weinstein R, Clark P, Balogun RA.&nbsp; Introduciton and overview of therapeutic apheresis.&nbsp; J Clin Apheresis, 2010.</li>
<li>Lok CE, <strong>Mokrzycki MH</strong>.&nbsp; Advances in Hemodialysis Catheter-related Infection.&nbsp; U.S. Nephrol, 2010.</li>
<li><strong>Mokrzycki MH</strong>, Lok CE. Traditional and nontraditional strategies to optimize catheter function: <em>Go with more flow.</em> Kidney Int, 2010.</li>
<li>Lok CE, <strong>Mokrzycki MH</strong>.&nbsp; Update 2010: Catheter-related Infection in Hemodialysis Patients. Kidney Int. 2010.</li>
<li>Lok CE, <strong>Mokrzycki MH</strong>.&nbsp; Prevention and management of catheter-related infection in hemodialysis patients.&nbsp; Kidney Int. 2010;79(6):587-98.</li>
<li><strong>Mokrzycki MH</strong>, Balogun RA.&nbsp; Therapeutic Apheresis: a review of complications and recommendations for prevention and management.&nbsp; J Clin Apher 2011:26(5):243-8.</li>
<li>Lee T, <strong>Mokrzycki MH</strong>, Moist L, Maya I, Vazquez M, Lok CE; North American Vascular Access Consortium. Standardized definitions for hemodialysis vascular access. Semin Dial 2011;24(5):515-24.</li>
<li>Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, <strong>Mokrzycki MH</strong>, Kimmel PL, Limous S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollack M, Winkler CA.&nbsp; APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-Associated nephropathy. J Am Soc Nephrol 2011;22(11):2129-37.</li>
<li>Sachdeva M, Hung A, Kovalchuk O, Bitzer M, <strong>Mokrzycki MH</strong>. The initial vascular access type contributes to inflammation in incident hemodialysis patients. Int J Nephrol Volume 2012; (2012) Article ID: 917465.</li>
<li>Lee T, Lok C, Vazquez M, Moist L, Maya I, <strong>Mokrzycki M</strong>.&nbsp; Minimizing hemodialysis catheter dysfunction: An ounce of prevention.&nbsp; Int J Nephrol; Volume 2012 (2012), Article ID: 170857.</li>
<li>Golestaneh L, <strong>Mokrzycki MH</strong>. Vascular Access in Therapeutic Apheresis: Update 2013.&nbsp; J Clin Apheresis. 2013: 28(1):64-72.</li>
<li>Nica A, Lok CE, Harris J, Lee TC, <strong>Mokrzycki MH</strong>, Maya ID, Vazquez MA, Xi W, Moist LM; From the North American Vascular Access Consortium (NAVAC). Understanding Surgical Preference and Practice in Hemodialysis Vascular Access creation. Semin Dial. 2013:26(4):520-526.</li>
<li>Bhatt DL, Kandzari DE, O&rsquo;Neill WW, D&rsquo;Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 2014;370 (15):1393-1401.</li>
<li><strong>Mokrzycki MH</strong>, Lok CE. Optimizing central venous catheter primary prevention trials in hemodialysis patients. Am. J.Kidney Dis. 2015;66(6):939-941.</li>
<li>Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson P, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova , Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, <strong>Mokrzycki MH</strong>, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M. Complete remission in the nephrotic syndrome study network. Clin J Am Soc Nephrol. 2016;11 (1):81-89.</li>
<li>Johns, TS, <strong>Mokrzycki MH</strong>. Optimal approach for the diagnosis of hemodialysis catheter-related bacteremia. Clin J Am Soc Nephrol 2016; 11.</li>
<li>Liang E, Rodriguez M, Mueller M, Abramowitz MK, <strong>Mokrzycki&nbsp; MH</strong>. Outcomes Associated with a Heparin-Free Hemodialysis Protocol and Review of the Literature. J. Clin. Nephrol. Renal Care. 2016, 2(1): 10-16.</li>
<li>Allon M, Brouwer-Maier DJ, Abreo K, Baskin KM, Bregel K, Chand D,&nbsp; Easom A, Mermel L, <strong>Mokrzycki MH</strong>, Patel PR, Roy-Chaudhury P, Shenoy S, Valentini RP, Wasse H.&nbsp; Moving Points in Nephrology: Recommended Clinical Trial Endpoints for Hemodialysis Catheters. Clin J Am Soc Nephrol. 2017</li>
<li>&nbsp;Golestaneh L, <strong>Mokrzycki MH</strong>. Prevention of Hemodialysis Catheters Infections: Ointments, Dressings, Locks and Catheter Hub Devices. Hemodial Int. Nov 2018</li>
<li>Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabathou S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, <strong>Mokrzycki M</strong>, Rominieki H, Graham JA, Rocca JP, Bornkamp N, Jordan N, Schulte E, Wu M, Pullman J, Slowikowski K, Raychaudhuri S, Guthridge J, James J, Buyon J, Tuschl T, Putterman C; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019 Jul;20(7):915-927</li>
<li>Fisher M, Golestaneh L, Allon M, <span style="font-family: 'Times New Roman', serif; font-size: 12pt;">&nbsp;</span><span style="font-family: 'Times New Roman', serif; font-size: 12pt;">Abreo K, </span><strong style="font-family: 'Times New Roman', serif; font-size: 12pt;">Mokrzycki MH.&nbsp;</strong>Preventing Central Vein Catheter Associated Bloodstream Infections in Hemodialysis: Review of Current Evidence-Based Strategies and Novel Therapies. <span style="font-size: 12pt; font-family: 'Times New Roman', serif;">Clin J Am Soc Nephrol 2020;15:132-151</span></li>
<li><span style="font-size: 12.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Vachharajani T , Wong L, Niyyar VD, Abreo KD, <strong>Mokrzycki MH</strong>, for the Vascular Access Workgroup of the Nephrologists Transforming Dialysis Safety Initiative of the American Society of Nephrology. Buttonhole cannulation of arteriovenous fistulas in the United States. Kidney360. 2020 </span></li>
<li><strong style="text-indent: -0.25in; font-family: 'Times New Roman', serif; font-size: 12pt;"><span style="font-size: 12pt;">Mokrzycki MH</span></strong><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;"> and Coco M. Management of hemodialysis patients with suspected or confirmed COVID-19 infection: perspective of two nephrologists in the United States. Kidney360. 2020:1(4);273-278.</span></li>
<li><span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;</span><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;">Fisher M, Yunes M, <strong>Mokrzycki MH</strong>, Golestaneh L, Alahiri E, Coco M. &ldquo;Chronic Hemodialysis Patients Hospitalized with COVID-19 &ndash; Short-term Outcomes in Bronx, New York&rdquo;. Kidney360 June 2020</span>1.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></li>
<li><strong style="text-indent: -0.25in;"><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Mokrzycki MH</span></strong><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;">, Leigh KA, Kliger AS, Niyyar VD, Bren Asp V, Golestaneh L, Taylor Q, Novosad SA. Implementation of an Electronic Catheter Checklist in Outpatient Hemodialysis Facilities: Results of a Pilot Quality Improvement Project. Kidney360&nbsp; April 2021, 2(4) 684-694</span>
<p class="MsoListParagraph" style="text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in;">&nbsp;</p>
</li>
</ol>
<p><em><strong><span style="text-indent: -0.25in; font-size: 12pt; font-family: 'Times New Roman', serif;">Book Chapter</span></strong></em></p>
<p class="MsoListParagraph" style="text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in;"><!-- [if !supportLists]--><span style="font-size: 12.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Times New Roman',serif;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';">&nbsp; &nbsp; &nbsp;</span></span></span><span style="font-size: 12.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Times New Roman',serif;">Fisher M, <strong style="mso-bidi-font-weight: normal;">Mokrzycki MH.</strong> Infectious complications in vascular access. Handbook of Dialysis. Nissenson: Handbook of Dialysis Therapy, 6e.</span> <span style="font-size: 12.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Times New Roman',serif;">Elsevir (In press, 2021)</span></p>

EMR ID

3774

Biography

<p>Michele H. Mokrzycki, MD, MS, is an attending nephrologist and Professor, Medicine at Montefiore Einstein. Dr. Mokrzycki&rsquo;s clinical interests include glomerular diseases, acute and chronic kidney diseases, hypertension, kidney stones, renal cystic diseases, dialysis and vascular access for hemodialysis.</p><p>After earning her Bachelor of Science from Boston College in 1983, Dr. Morkrzycki pursued her Doctor of Medicine at University of Vermont College of Medicine, earning the degree in 1987. She performed her postdoctoral training at University of Connecticut Health Center, completing her residency in internal medicine in 1990 and her fellowship in clinical nephrology in 1992. Dr. Mokrzycki later pursued additional education, completing her Master of Science in clinical research at Einstein in 2000.</p><p>Author of over 50 peer-reviewed publications, Dr. Mokrzycki&rsquo;s research focuses on reducing hemodialysis vascular access infectious and thrombotic complications. She is on the editorial board for <em>Kidney360</em>, and is an invited reviewer for several publications including the <em>Journal of the American Society of Nephrology, Hemodialysis International</em> and the <em>Journal of Vascular Access.</em></p><p>Dr. Mokrzycki is board certified in Nephrology. She is a Fellow of the American Society of Nephrology and a member of several professional societies including the National Kidney Foundation, New York Society of Nephrology and the North American Vascular Access Consortium. In 2020, she was recognized as Reviewer of the Year by <em>Kidney360</em>.</p>

Is Open Scheduling

On

Deep Sharma

https://assets.montefioreeinstein.org/profiles/images/physphoto/Sharma_Deep_MD_420x504.jpg

First Name

Deep

Last Name

Sharma

NPI

1578759338

Faculty ID

12095

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Kidney stones, Glomerular diseases, Chronic kidney disease, End Stage renal disease&nbsp;

Research Focus

Treatment for anemia in patients with chronic kidney disease and end stage renal disease on dialysis

Elsevier Profile

EMR ID

5356

Biography

<p></p>Deep Sharma, MBBS, earned his medical degree from University College of Medical Sciences in Delhi, India. He then completed his residency and chief residency at Good Samaritan Hospital, Baltimore followed by his nephrology fellowship at Montefiore Medical Center where he joined as faculty after completion of his fellowship. He is board certified in Medicine and Nephrology and is a member of the American Society of Nephrology. Dr. Sharma is the clinical director of Nephrology for Weiler Hospital and the medical director of Fresenius Eastchester and Fresenius Freedom Center of the Bronx that treats patients who need dialysis for End Stage Kidney disease, both incenter and at home. With the help of his Urology colleagues, he helped establish the kidney stone program at Montefiore and that sees patients with kidneys stones in the clinic. Dr. Sharma has been involved in clinical studies looking at muscle mass in patients with kidney disease and the treatment of anemia in patients with chronic kidney disease and dialysis.<p></p>

Visit Type ID

2541

Is Open Scheduling

On

Michael J. Ross

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ross_Michael_MD_420x504.jpg

First Name

Michael

Last Name

Ross

NPI

1851321368

Faculty ID

15329

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="p1">&nbsp;</p>
<p class="p1">The major focus of research in the Ross laboratory is to identify novel mechanisms of kidney injury occurring in HIV-positive persons and his laboratory uses in vitro and murine models to generate new strategies to prevent and treat kidney diseases. Dr. Ross also works with members of the International Network for Strategic Initiatives in Global HIV Treatment (INSIGHT) to perform research on kidney disease in the context of large international HIV treatment trials.</p>
<p class="p1"><strong><span style="text-decoration: underline;">Ongoing NIH-funded projects:</span></strong></p>
<p class="p1"><strong>Mechanisms by which antiretroviral medications protect kidneys from HIV-induced injury:</strong></p>
<p class="p1">Though combination antiretroviral therapy (cART) is efficacious in preventing and treating HIV-associated nephropathy (HIVAN), the mechanisms by which these medications protect the kidney from the deleterious effects of HIV are poorly understood.&nbsp;&nbsp;We are performing studies using transgenic animal models and molecular and genomic techniques to identify novel pathways by which ART protect the kidneys from HIV.&nbsp;&nbsp;Moreover, we have exciting data suggesting that these medications may protect kidneys from non-viral mediated forms of kidney injury, including diabetic kidney disease.</p>
<p class="p1"><strong>The role of APOL1 polymorphisms in promoting HIV-induced kidney injury:</strong></p>
<p class="p1">Polymorphisms in the APOL1 gene account for most of the excess risk of African-Americans to non-diabetic kidney disease and HIV-associated kidney disease in particular. In our studies, we are using genetically modified human kidney cells to perform innovative proteomic, and genomic studies to identify novel mechanisms by APOL1 genetic variants predispose to HIV-induced kidney injury.&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p><span style="color:black;">Chronic kidney disease, diabetic kidney disease, acute kidney injury, glomerular diseases, cystic kidney diseases, electrolyte disorders, hypertension, HIV and other virus-related kidney diseases.</span></p>

Research Focus

<p><span style="color:black;">The primary focus of Dr. Ross' research is to identify mechanisms by which HIV and immune dysregulation cause kidney disease and to identify new approaches to prevent and treat kidney disease. Dr. Ross is also involved in clinical studies to determine mechanisms of diabetic kidney injury and to test the effectiveness of novel treatments for chronic kidney diseases.</span></p>

Elsevier Profile

Selected Publications

<p><span style="text-decoration: underline;"><strong>Most relevant publicatiion in past 10 years:</strong></span></p>
<p>*Mocroft, A., Wyatt, C., Szczech, L., Neuhaus, J., El-Sadr, W., Tracy, R., Kuller, L., Shlipak, M., Angus, B., Klinker, H., and <strong><span style="text-decoration: underline;">Ross, MJ</span></strong>. Interruption of antiretroviral therapy is associated with increased plasma cystatin C: Results from the SMART Study. <em>AIDS</em>. 23, 71-82. 2009.</p>
<p>*Snyder A, Alsauskas Z, Gong P, Rosenstiel P, Klotman M, Klotman P, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>: FAT10: a novel mediator of Vpr-induced apoptosis in HIV-associated nephropathy. <em>J Virol</em>. 83;11983-11988. 2009.</p>
<p>*Gong, P., Canaan, A., Wang, B., Leventhal, S., Snyder, A., Nair, V., Cohen, C. D., Kretzler, M., D'Agati, V., Weissman, S., and <strong><span style="text-decoration: underline;">Ross, M. J</span></strong>. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 21:316. 2009.</p>
<p>Snyder A, Alsauskas ZC, Leventhal JS, Rosenstiel PE, Gong P, Chan J, Barley K, He C, Klotman M, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Klotman PE. HIV-1 viral protein r induces ERK and caspase-8 dependent apoptosis in renal tubular epithelial cells. <em>AIDS</em>, 24:1107-1119. 2010.</p>
<p>Neuhaus, J., Jacobs, D.R., Baker, J.V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L., Pett, S.L., Ristola, M., <strong><span style="text-decoration: underline;">Ross, M.J.</span></strong>, Shlipak, M., Tracy, R., and Neaton, J.D. Markers of Inflammation, Coagulation and Renal Function Are Elevated in Adults with HIV Infection. <em>J Infect Dis</em>. 201:1788-1795. 2010.</p>
<p>Chen, P., Chen, B.K., Mosoian, A., Hays, T., <strong><span style="text-decoration: underline;">Ross, M.J</span></strong>., Klotman, P.E., and Klotman, M.E. Virological Synapses Allow HIV-1 Uptake and Gene Expression in Renal Tubular Epithelial Cells. J Am Soc Nephrol. &nbsp;22(3): 496-507. 2011.</p>
<p>Leventhal, J.S., Alsauskas, Z., Snyder, A., Gong, P., Wang, B., D&rsquo;Agati, V., and <strong><span style="text-decoration: underline;">Ross, M.J.</span></strong> Renal HIV Expression Is Unaffected by Serum LPS Levels in an HIV Transgenic Mouse Model of LPS Induced Kidney Injury. <em>PLoS One.</em> <strong>6</strong>:e20688. 2011.</p>
<p>Papeta, N., Kiryluk, K., Patel, A., Sterken, R., Kacak, N., Snyder, H.J., Imus, P.H., Mhatre, A.N., Lawani, A.K., Julian, B.A., Wyatt, R.J., Novak, J., Wyatt, C.M., <strong><span style="text-decoration: underline;">Ross, M.J.</span></strong>, Winston, J.A., Klotman, M.E., Cohen, D.J., Appel, G.B., D&rsquo;Agati, V.D., Klotman, P.E., and Gharavi, A.G. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. <em>J Am Soc Nephrol.</em> 22:1991-1996. 2011.</p>
<p>Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>*, Wyatt CM*: Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults. PLoS ONE 7:e40245, (*co-senior authors). 2012.</p>
<p>Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD: Exposure to Antiretrovirals (ARVs) and Risk of Renal Impairment among HIV-positive Persons with Normal Baseline Renal Function: the D:A:D study. J Infect Dis 2013.</p>
<p>Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Crum-Cianflone NF: Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care. HIV Med 14:65-76, 2013</p>
<p>Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 1;207(9):1359-69. 2013.</p>
<p>Lucas, G., Cozzi-Lepri, A., Wyatt, C., Post, F., Bormann, A., Crum-Cianflone, N., and <strong><span style="text-decoration: underline;">Ross, M</span></strong>. Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. HIV Med 15:116-123. PubMed PMID: 24024499. 2014.</p>
<p>Lucas, GM, <strong><span style="text-decoration: underline;">Ross, MJ</span></strong>, Stock, PG, Shlipak, MG, Wyatt, CM, Gupta, SK, Atta, MG, Wools-Kaloustian, KK, Pham, PA, Bruggeman, LA, Lennox, JL, Ray, PE, and Kalayjian, RC. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update By the HIV Medicine Association of the Infectious Diseases Society of America. <em>Clin Infect Dis</em>; 59(9), e96-e138. 2014.</p>
<p>Ryom, L., Mocroft, A., Kirk, O., <strong><span style="text-decoration: underline;">Ross, M</span></strong>., Reiss, P., Fux, C. A., Morlat, P., Moranne, O., Smith, C., El-Sadr, W., Law, M., and Lundgren, J. D. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS 28, 187-199. 2014.</p>
<p>Mocroft A, Lundgren J, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events&nbsp; (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study&nbsp; group. A clinically useful risk-score for chronic kidney disease in HIV infection. J Int AIDS Soc ;17(4 Suppl 3):19514.. PMID: 25394023; PMCID: PMC4224906. 2014.</p>
<p>Leventhal, J.S., He, J.C., and <strong><span style="text-decoration: underline;">Ross, M.J</span></strong><span style="text-decoration: underline;">.</span> Autophagy and Immune Response in Kidneys. <em>Semin Nephrol.</em> 34(1):53-61. 2014.</p>
<p><strong><span style="text-decoration: underline;">Ross, M. J.</span></strong> (2014). Advances in the pathogenesis of HIV-associated kidney diseases. <em>Kidney Int.</em> 86, 266-274. 2014.</p>
<p>Mocroft A, Lundgren JD, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar 31;12(3):e1001809. PMID: 25826420; PMCID: PMC4380415. 2015.</p>
<p>Wolf T, <strong><span style="text-decoration: underline;">Ross MJ*</span></strong>, and Davenport A. Minimizing risks associated with renal replacement therapy in patients with Ebola Virus Disease. <em>Kidney Int.</em> 2015. 87, 5-7. 2015.</p>
<p>Achhra AC, Mocroft A, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Ryom L, Lucas GM, Furrer H, Neuhaus J, Somboonwit C, Kelly M, Gatell JM, Wyatt CM; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group. Kidney disease in antiretroviral-na&iuml;ve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med;16 Suppl 1:55-63. PMID: 25711324; PMCID: PMC4341947. 2015.</p>
<p>Mocroft A, Lundgren JD, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. Lancet HIV. 3:e23-32. 2016.</p>
<p>Leventhal JS, Ni J, Osmond M, Lee K, Gusella GL, Salem F, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>. Autophagy Limits Endotoxemic Acute Kidney Injury and Alters Renal Tubular Epithelial Cell Cytokine Expression. PLoS One. 11(3):e0150001. 2016.</p>
<p>Ryom, L, Lundgren, JD, <strong><span style="text-decoration: underline;">Ross, M</span></strong>, Kirk, O, Law, M, Morlat, P, Smit, C, Fontas, E, Fux, CA, Hatleberg, CI, de Wit, S, Sabin, CA, Mocroft, A, D:A:D, SG. Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study. J Infect Dis. PMID: 27485357. 2016.</p>
<p>Ryom L, Mocroft A, Kirk O, Reiss P, <strong><span style="text-decoration: underline;">Ross M,</span></strong> Smith C, Moranne O, Morlat P, Fux CA, Sabin C, Phillips A, Law M, Lundgren JD; D:A:D study group.. Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals. AIDS. 2017 Mar 28. PMID: 28353536.</p>
<p>Nadkarni GN, Wyatt CM, Murphy B, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>. APOL1: a case in point for replacing race with genetics. Kidney Int. 2017 Apr;91(4):768-770. PMID: 28314574.</p>
<p>Rednor SJ, <strong>Ross MJ</strong>. Molecular Mechanisms of Injury in HIV-Associated Nephropathy. Front Med (Lausanne). 2018; 5:177. PMID: 29930940 PMCID: PMC5999756</p>
<p><strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Coates PT. Using CRISPR to inactivate endogenous retroviruses in pigs: an important step toward safe xenotransplantation. Kidney Int. 2018; 93:4-6, PMID: 29198467.</p>
<p><strong><span style="text-decoration: underline;">Ross MJ.</span></strong> New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease. Kidney Int Rep. 2019; 4:908-910 PMC6611947.</p>
<p>Ryom L, Dilling Lundgren J, Reiss P, Kirk O, Law M, <strong><span style="text-decoration: underline;">Ross M</span></strong>, Morlat P, Andreas Fux C, Fontas E, De Wit S, D'Arminio Monforte A, El-Sadr W, Phillips A, Ingrid Hatleberg C, Sabin C, Mocroft A. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. J Infect Dis. 2019 Oct 8;220(10):1629-1634. doi: 10.1093/infdis/jiz369. PubMed PMID: 31504669; PubMed Central PMCID: PMC6782100.</p>
<p>Gao X, Rosales A, Karttunen H, Bommana GM, Tandoh B, Yi Z, Habib Z, Agati V, Zhang W, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>. The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms. Sci Rep. 2019 Nov 1;9(1):15857. doi: 10.1038/s41598-019-52278-3. PubMed PMID: 31676833; PubMed Central PMCID: PMC6825220.</p>
<p>Townsend RR, Guarnieri P, Argyropoulos C, Blady S, Boustany-Kari CM, Devalaraja-Narashimha K, Morton L, Mottl AK, Patel U, Palmer M, <strong><span style="text-decoration: underline;">Ross MJ</span></strong>, Sarov-Blat L, Steinbugler K, Susztak K. Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020. PubMed PMID: 31901339.</p>
<div class="citation-text" data-citation-style="ama">Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, <strong><span style="text-decoration: underline;">Ross M,</span></strong> Forest S, Goldstein YD, Ajaimy M, Liriano-Ward L, Pynadath C, Loarte-Campos P, Nandigam PB, Graham J, Le M, Rocca J, Kinkhabwala M. Covid-19 and Kidney Transplantation. N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24. PMID: 32329975; PMCID: PMC7200055.</div>

EMR ID

1540

Biography

<p>Dr. Michael Ross received his MD degree at NYU and completed internal medicine residency training at Duke University, followed by Nephrology Fellowship training at the Icahn School of Medicine at Mount Sinai. While he was on the faculty in the Mount Sinai Division of Nephrology from 2001-17, he served as Nephrology Fellowship Program Director from 2004-2015. He became Chief of Nephrology at the James J. Peters VA Medical Center from 2014-2017, where he helped establish the only VA Kidney Transplant Program in the northeastern US. Dr. Ross became Chief of the Division of Nephrology at the Albert Einstein College of Medicine/Montefiore Medical Center in 2017 where he is currently Chief of Nephrology and Professor of Medicine and Developmental and Molecular Biology.&nbsp;</p><p>Dr. Ross has served in several national/international leadership roles for the American Society of Nephrology and other organizations, served as Deputy Editor of Kidney International, and is currently Nephrology Section Editor of the American College of Physicians Medical Knowledge and Self-Assessment Program. Dr. Ross was also the recipient of the 2021 American Society of Nephrology Distinguished Leader Award. The major focus of Dr. Ross&rsquo; research program is to identify novel mechanisms of HIV-induced kidney diseases and other forms of kidney injury. He is also site principal investigator of clinical and translational research studies of diabetic kidney disease and other kidney diseases.&nbsp;<br /></p>

Is Open Scheduling

Off

Amanda C. Raff

https://assets.montefioreeinstein.org/profiles/images/physphoto/Raff_Amanda_MD_420x504.jpg

First Name

Amanda

Last Name

Raff

NPI

1952490369

Faculty ID

8749

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff is a Professor of Medicine and the Associate Chair of Medicine for Undergraduate Medical Education. She has been the Course Director for the Einstein first year medical student Renal System Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She a faculty mentor for the student led Step 1 Group near-peer evidence based guidance program and the Internal Medicine Interest Group.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She has a clinical practice of CKD and ESRD patients and enjoys rounding on the inpatient Renal Consult and Dialysis services.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">Dr. Raff&rsquo;s contributions in the field of Medical Education include serving as a Case Editor for&nbsp;&nbsp;Aquifer Internal Medicine, contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision and MKSAP 19 Nephrology section committee member.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">She has been recognized for her teaching excellence at Einstein with the Samuel M. Rosen Outstanding Teacher Award for Excellence in Basic Science Teaching, the Harry Eagle Award for Outstanding Basic Science Teaching, the Harry H. Gordon Award for Outstanding Clinical Teaching and membership in the Leo M. Davidoff Society.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff received a bachelor's degree in biology from Indiana University and a MD from Albert Einstein College of Medicine. She completed a residency in Internal Medicine at NewYork Presbyterian Hospital and a chief resident year at NYU Downtown Hospital. She returned to Einstein/Montefiore for a Nephrology Fellowship and joined the Einstein Division of Nephrology faculty in 2004.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Autosomal Dominant Polycystic Kidney Disease (ADPKD)<br />Chronic Kidney Disease (CKD)<br />End Stage Kidney Disease (ESKD, ESRD)<br />Acute Kidney Injury (AKI)<br />Glomerular diseases<br />Hypertension<br />Electrolyte Disorders<br />Kidney Stones<br />

Research Focus

<p><span style="color:black;">&nbsp;</span></p>

Elsevier Profile

Selected Publications

<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">1.&nbsp;</span><span style="font-size: 12pt; font-family: Cambria; color: #212121;">Fitz M, Adams W, Haist S, Hauer K, Ross P,&nbsp;<strong>Raff A</strong>, Agarwal G, Vu T, Appelbaum J, Lang V, Miller C, Grum C and the Clerkship Directors in Internal Medicine &ndash; National Board of Medical Examiners EXPRESS Study Group. Which Internal Medicine Clerkship Characteristics Are Associated With Students' Performance on the NBME Medicine Subject Exam? A Multi-Institutional Analysis.&nbsp;<em>Acad Med</em>. 2020;10.1097/ACM.0000000000003322 [published online ahead of print, 2020 Mar 17].&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">2.&nbsp;</span><span style="font-size: 12pt; font-family: Cambria;">Brien K (Author), Calvo L (Associate editor),&nbsp;<strong>Raff A</strong>&nbsp;(Case editor).&nbsp;<em>Aquifer Internal Medicine Case 33: 49-year-old woman with confusion</em>. 2019&nbsp;</span><u><span style="font-size: 12pt; font-family: Cambria; color: #3366ff;">https://www.aquifer.org</span></u></p&gt;
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">3.&nbsp;</span><span style="font-size: 12pt; font-family: Cambria;">Khan M, Gil N, Lin W, Fiter R, Kenawy D, Burton W,&nbsp;<strong>Raff A</strong>.&nbsp;&nbsp;The impact of Step 1 scores on medical students&rsquo; residency specialty choice.&nbsp;<em>Med Sci Educ.</em>&nbsp;28(4): 699-705. 2018.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">4.&nbsp;Ludwig A,&nbsp;<strong>Raff A</strong>, Lin J, Schoenbaum E. Group Observed Structured Encounter (GOSCE) for third year medical students improves self-assessment of clinical communication.&nbsp;<em>Medical Teacher</em>&nbsp;39(9): 931-5.&nbsp;2017.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">5.&nbsp;Golestaneh L, Neugarten J, Southern W, Kargoli F,&nbsp;<strong>Raff A</strong>.&nbsp;&nbsp;Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiative.&nbsp;<em>Int Urol Nephrol</em>&nbsp;49(3): 491-7. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">6.&nbsp;Czapka M,&nbsp;<strong>Raff A</strong>, Risley M.&nbsp;&nbsp;Safe Transitions: An active learning module for discharge summaries and interprofessional care.&nbsp;<em>MedEdPORTAL&nbsp;iCollaborative</em>. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">7.&nbsp;Tanenbaum, E, Johnson J, Jordan, E, Cottral J, Tenore C, Burton W, McGinn A<strong>, Raff A</strong>.&nbsp;&nbsp;An effective evidence-based student run near-peer support group for the USMLE Step 1 Exam.&nbsp;&nbsp;<em>Med Sci Educ</em>. 26(4): 691-9. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">8.&nbsp;Ludwig A, Lee R, Parish S,&nbsp;<strong>Raff A</strong>. Four-station group observed structured clinical encounter for formative assessment of communication skills for internal medicine clerks.&nbsp;<em>MedEdPORTAL Publications</em>. 12:10444. 2016&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">9.&nbsp;Chen W, Melamed M, Hostetter T, Bauer C,&nbsp;<strong>Raff A</strong>, Almudevar A, Lalonde A, Messing S, Abramowitz M.&nbsp;&nbsp;Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.&nbsp;&nbsp;<em>BMC Nephrol</em>. 17(1): 114. doi: 10.1186/s12882-016-0331-6. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">10.&nbsp;Jion Y,&nbsp;<strong>Raff A</strong>, Grosberg B, Evans R.&nbsp;&nbsp;The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.&nbsp;&nbsp;<em>Headache</em>. 55(1): 161-6. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">11. Jion Y,&nbsp;<strong>Raff A</strong>, Grosberg B, Evans R.&nbsp;&nbsp;Topiramate and nephrolithiasis: a response.&nbsp;&nbsp;<em>Headache</em>. 55(5): 710-2. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">12.&nbsp;Abramowitz, M, Melamed M, Bauer C,&nbsp;<strong>Raff A</strong>, Hostetter T.&nbsp;&nbsp;Effects of oral sodium bicarbonate in patients with CKD.&nbsp;&nbsp;<em>Clin J Am Soc Nephrol</em>. 8(5): 714-20. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">13. Berman N, Lectura M, Thurman J, Reinecke J,&nbsp;<strong>Raff A</strong>, Melamed M, Quan Z, Evans T, Meyer T, Hostetter T.&nbsp;&nbsp;A zebrafish model for uremic toxicity: role of the complement pathway.&nbsp;&nbsp;<em>Blood Purif</em>. 35(4): 265-9. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">14.&nbsp;Bomback A,&nbsp;<strong>Raff A</strong>.&nbsp;&nbsp;Olfactory function in dialysis patients: a potential key to understanding the uremic state.&nbsp;&nbsp;<em>Kidney Int</em>.&nbsp;&nbsp;80(8): 803-5.&nbsp;&nbsp;2011</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">15.&nbsp;Ponda M, Quan Z, Melamed M,&nbsp;<strong>Raff A</strong>, Meyer T, Hostetter T.&nbsp;&nbsp;&nbsp;Methylamine clearance by haemodialysis is low.&nbsp;&nbsp;<em>Nephrol Dial Transplant</em>.&nbsp;&nbsp;25(5): 1608-13. 2010</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">16.&nbsp;<strong>Raff A</strong>,&nbsp;&nbsp;Lieu S, Melamed M, Quan Z, Ponda M, Meyer T, Hostetter T.&nbsp;&nbsp;Relationship of Impaired Olfactory Function in ESRD to Malnutrition and Retained Uremic Molecules.&nbsp;<em>Am J Kidney Dis</em>.&nbsp;&nbsp;52(1): 102-10.&nbsp;&nbsp;2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">17.&nbsp;<strong>Raff A</strong>, Meyer T, Hostetter T.&nbsp;&nbsp;New Insights into uremic toxicity.&nbsp;&nbsp;<em>Curr Opin Nephrol Hypertens</em>.&nbsp;&nbsp;17(6): 560-5.&nbsp;&nbsp;2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">18.&nbsp;Susztak K,&nbsp;<strong>Raff A</strong>, Schiffer M, Bottinger E.&nbsp;&nbsp;Glucose &ndash; induced&nbsp;&nbsp;&nbsp;reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.&nbsp;<em>Diabetes</em>. 55(1): 225-33.&nbsp;&nbsp;2006</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">19.&nbsp;Schiffer M. Susztak K, Ranalletta M,&nbsp;<strong>Raff A</strong>, Bottinger E, Charron M.&nbsp;&nbsp;Localization of the GLUT8 transporter in murine kidney and regulation in vivo in non-diabetic and diabetic conditions.&nbsp;&nbsp;<em>Am J Physiol Renal Physiol</em>, 289(1): F186-193.&nbsp;&nbsp;2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">20.&nbsp;<strong>Raff A</strong>, Hebert T, Pullman J, Coco M.&nbsp;&nbsp;Crescentic post-streptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted?&nbsp;&nbsp;<em>Clinical Nephrology</em>, 63(5): 375-380.&nbsp;&nbsp;2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">21.&nbsp;Spector M,&nbsp;<strong>Raff A</strong>, DeSilva H, Lee K, Osley M.&nbsp;&nbsp;Hir1p and Hir2p function as transcriptional corepressors to regulate histone gene transcription in&nbsp;<em>Saccharomyces cerevisiae&nbsp;</em>cell cycle.&nbsp;<em>&nbsp;Molecular and Cellular Biology</em>, 17(2):&nbsp;&nbsp;545-552.&nbsp;&nbsp;1997</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">22.&nbsp;Recht J, Dunn B,&nbsp;<strong>Raff A</strong>, Osley M.&nbsp;&nbsp;Functional analysis of histone H2A and H2B in transcriptional repression in&nbsp;<em>Saccharomyces cerevisiae. Molecular and Cellular Biology</em>, 16(6):&nbsp;&nbsp;2545-2553<em>.</em>&nbsp;&nbsp;1996</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">23.&nbsp;Kopczynski J,&nbsp;<strong>Raff A</strong>, Bonner J.&nbsp;&nbsp;Translational readthrough at nonsense mutations in the&nbsp;<em>HSF1</em>&nbsp;gene of&nbsp;<em>Saccharomyces cerevisiae.&nbsp;</em>&nbsp;<em>Molecular and General Genetics</em>, 234: 369-378.&nbsp;&nbsp;1992</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: 'Times New Roman';">&nbsp;</span></p>

EMR ID

4469

Biography

<p>Amanda C. Raff, MD, is Attending Physician, Professor and Associate Chair of Medicine for Undergraduate Medical Education at Montefiore-Einstein. She is also the co-director of the Montefiore-Einstein Autosomal Dominant Polycystic Kidney Disease Program. Dr. Raff&rsquo;s clinical focus is on dialysis and the treatment of patients with chronic kidney disease and end stage kidney disease.</p><p>After earning her Bachelor of Science in biology at Indiana University, Dr. Raff completed her Doctor of Medicine at Albert Einstein College of Medicine, earning her degree in 1998.&nbsp; Her postdoctoral training began at New York Presbyterian Hospital with an internship and residency in internal medicine from 1998 through 2001. She was assistant chief resident at Memorial Sloan Kettering Cancer Center in 2000 and chief resident at New York University Downtown Hospital from 2001 to 2002. She then returned to Montefiore-Einstein to complete a two-year fellowship in nephrology in 2004.</p><p>Dr. Raff&rsquo;s research focuses on medical education. She has been the Course Director for the Einstein medical student Renal Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012. Dr. Raff&rsquo;s contributions in the field of Medical Education include serving as a Nephrology section committee member for the American College of Physicians&rsquo; Medical Knowledge Self-Assessment Program (MKSAP) 19 and 20 as well as prior work as a Case Editor for Aquifer Internal Medicine and contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision.</p><p>An enthusiastic medical educator, Dr. Raff has received several awards for her teaching and in 2010 was inducted into the Leo M. Davidoff Society for outstanding achievement in the teaching of medical students. She is board certified and is a member the American Society of Nephrology and a fellow of the American College of Physicians.</p>

Visit Type ID

2541

Is Open Scheduling

On

Cindy T. Pynadath

https://assets.montefioreeinstein.org/profiles/images/physphoto/Pynadath_Cindy_DO_420x504.jpg

First Name

Cindy

Last Name

Pynadath

NPI

1205062460

Faculty ID

16837

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Kidney and Pancreas Transplantation

Research Focus

Dr. Pynadath&rsquo;s current research interest in Transplant Medicine explores its connection to infectious disease and mineral bone and metabolic disorders, as well as the clinical outcomes in kidney transplant.&nbsp; Her work collaborations have been published in reputed journals, as well as presented at national and international transplant conferences.&nbsp;&nbsp;

Elsevier Profile

EMR ID

7261

Biography

<p>Cindy T. Pynadath, DO, is a Transplant Nephrologist and Assistant Professor, Medicine at Montefiore Einstein. Her clinical focus centers on kidney and pancreas transplantation.</p><p>After obtaining her Bachelor of Science in integrated life sciences from Kent State University in 2005, Dr. Pynadath earned her Doctor of Osteopathic Medicine at Ohio University College of Osteopathic Medicine in 2009. She then completed her internal medicine residency at the Cleveland Clinic Foundation in 2012 before completing a nephrology fellowship at University Hospitals Case Medical Center in 2014. Following this, Dr. Pynadath completed a transplant nephrology fellowship at the same institution in 2015.</p><p>Dr. Pynadath&rsquo;s current research in transplant medicine explores its connection to infectious disease and mineral bone and metabolic disorders, as well as the clinical outcomes in kidney transplantation. Her work collaborations have been published in a number of reputed journals, as well as presented at national and international transplant conferences.</p><p>Dr. Pynadath is board certified by the American Board of Internal Medicine. She is a member of multiple professional associations including the American Society of Transplantation (AST) and the American Society of Nephrology (ASN). She is a past recipient of the Caregiver Celebrations Appreciation Award for exemplary clinical and patient care from the Cleveland Clinic Foundation.</p>

Is Open Scheduling

Off

Joel Neugarten

https://assets.montefioreeinstein.org/profiles/images/physphoto/Neugarten_Joel_MD_420x504.jpg

First Name

Joel

Last Name

Neugarten

NPI

1750466520

Faculty ID

1225

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Acute and Chronic Kidney Disease<span style="font-size:10.5pt;font-family:'Arial',sans-serif;color:#5B5B5B;"></span></p>

Research Focus

Dr. Neugarten's main research interest is investigating mechanisms of acute and chronic kidney injury

Elsevier Profile

Selected Publications

<p><ol>
<li>Neugarten J. Estrogen and oxidative stress. Gend Med. Mar;4(1):31-2. 2007.</li>
<li>Silbiger S, Neugarten J. Gender and human renal disease. Gend Med.5: Suppl A:S3-S10. Review</li>
<li>Neugarten J: Estrogen and reactive oxygen species. Gender Med. . 2008</li>
</ol></p>

EMR ID

3415

Biography

Dr. Joel Neugarten is currently Professor of Medicine at the Albert Einstein College of Medicine, Medical Director of the Bedford Park Dialysis Unit, and an Attending Nephrologist at Montefiore Medical Center in the Bronx, New York. He is a graduate of the Albert Einstein College of Medicine and the Brooklyn Law School and completed his post graduate training at Mount Sinai Medical Center in New York and at New York University Medical Center. He previously served as Site Director of the Nephrology Division of Montefiore Medical Center and as President of the New York Society of Nephrology. He is an author of over 100 peer reviewed publications and book chapters dealing with numerous aspects of Nephrology. His major research interests include factors that influence the progression of chronic kidney disease and the management of patients with chronic kidney disease.

Visit Type ID

2541

Is Open Scheduling

On

Tina M. Neade

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/7bb3fcb0-c3cc-11eb-9ea2-7374238588d1.jpg

First Name

Tina

Last Name

Neade

NPI

1538331061

Faculty ID

16814

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease, Glomerular disease, End stage renal disease, Kidney stones and Hypertension

Elsevier Profile

EMR ID

52322

Biography

Tina Neade, M.D., is an Assistant Professor of Medicine in the Division of Nephrology at Montefiore Medical Center/ Albert Einstein College of Medicine. She earned her medical degree at Albert Einstein College of Medicine, New York in 2002. She then completed her internal medicine residency at Mount Sinai Hospital in New York in 2005, followed by a nephrology fellowship at Mount Sinai Hospital in 2008. Dr Neade joined the faculty at Montefiore Medical Center in 2017. Dr. Neade is board certified in Internal Medicine and Nephrology.&nbsp;

Visit Type ID

2541

Is Open Scheduling

On

Michal L. Melamed

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/66412790-2b53-11ee-9f8d-1b267177a44e.jpg

First Name

Michal

Last Name

Melamed

NPI

1407953235

Faculty ID

10492

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Michal Melamed is a Professor of Medicine and Epidemiology &amp; Population Health at the Albert Einstein College of Medicine. She has been the Nephrology Fellowship Program Director since 2012. After completing her undergraduate degree in Dramatic Literature at New York University <em>summa cum laude</em>, she trained at Johns Hopkins School of Medicine for medical school, Internal Medicine residency, and Nephrology fellowship. Additionally, she completed a Masters in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health during her fellowship.</p>
<p>She has been continuously funded by the National Institutes of Health since 2007 and her research interests include the epidemiology of chronic kidney disease and its complications, the epidemiology and health consequences of Vitamin D deficiency and metabolic acidosis. Dr. Melamed is the Principal Investigator of several NIH-funded research studies.&nbsp; She has published over 90 original publications in the medical literature and has mentored countless young investigators from high school students to junior faculty members. In 2019, she won the Distinguished Mentor Award from the American Society of Nephrology.</p>
<p>&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Selected Publications:<br />&nbsp;<br /><strong>Melamed ML</strong>, Eustace JA, Plantinga L, Jaar BG, Fink NE, Klag MJ, Coresh J, Powe NR. Changes in Serum Calcium, Phosphate and PTH and the Risk of Death in Incident Dialysis Patients: A Longitudinal Study. Kidney Int 2006 Jul;70(2):351-7.<br />&nbsp;<br />Gupta R, Plantinga LC, Fink NE, <strong>Melamed ML</strong>, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007 Apr 4;297(13):1455-64.<br />&nbsp;<br />Hailpern SM, <strong>Melamed ML</strong>, Cohen HW, Hostetter T.&nbsp; Moderate Chronic Kidney Disease and Cognitive Function in Adults 20-59 Years of Age (NHANES III). J Am Soc Nephrol 2007 Jul;18(7):2205-13.<br />&nbsp;<br /><strong>Melamed ML,</strong> Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Third-Generation Parathyroid Hormone Assays and All-Cause Mortality in Incident Dialysis Patients: The CHOICE Study. Nephrol Dial Transplant. 2008 May; 23(5):1650-8.</p>
<p><strong>Melamed ML*, </strong>Muntner P*, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25-hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001-2004. Atheroscler Thromb Vasc Biol. 2008 Jun;28(6)1179-85.<br />&nbsp;<br /><strong>Melamed ML*, </strong>Michos ED*, Post W, Astor B. 25-Hydroxyl Vitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. 2008 Aug 11;168(15):1629-37.<br />&nbsp;<br />Shah S, Abramowitz M, Hostetter TH, <strong>Melamed ML</strong>. Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study. Am J Kidney Dis. 2009 Aug;54(2):270-7.<br />&nbsp;<br />Kumar J, Muntner P, Kaskel FJ, Hailpern SM, <strong>Melamed ML</strong>. Prevalence and Associations of 25- Hydroxyvitamin D Deficiency in Children and Adolescents in the United States: Results from NHANES 2001-2004. Pediatrics. Aug 3 2009. Electronic pages.<br />&nbsp;<br />Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, <strong>Melamed ML</strong>, Powe NR, Jaar BG. Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis. Clin J Am Soc Nephrol. 2009 Oct;4 (10):1637-45.<br />&nbsp;<br />Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, <strong>Melamed ML</strong>, Wiebe N, Muntner P. Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality. Circulation. 2009 Oct. 19 Epub. 2009 Nov 3;120(18):1784-92.<br />&nbsp;<br /><strong>Melamed ML</strong>, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-Hydroxyvitamin D levels, Race and the Progression of Kidney Disease. J Am Soc Nephrol. 2009 Dec.;20(12) 2631-9.<br />&nbsp;<br />Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, <strong>Melamed ML</strong>. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol. 2010 Apr 8 Epub. 2010 Jun;5(6):1064-71.<br />&nbsp;<br />Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, <strong>Melamed ML</strong>, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010 June 9; 78(5):514-22.<br />&nbsp;<br /><strong>Melamed ML, </strong>Blackwell T, Neugarten J, Arnsten J, Ensrud K, Ishani A, Cummings S, Silbiger S. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int. 2011 Jan;79(2):241-9<br /><strong>&nbsp;</strong><br />O&rsquo; Seaghdha CM, Hwang S-J, Muntner P, <strong>Melamed ML</strong>*, Fox CS*. Serum phosphorus predicts incident Chronic Kidney Disease and End-Stage Renal Disease. Nephrol Dial Transplant 2011 Sep;26(9):2885-90. Epub 2011 Feb 3.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Association of Serum Bicarbonate Levels with Gait Speed and Quadriceps Strength in Older Adults. Am J Kidney Dis 2011 Feb 25.<br />&nbsp;<br />Sharief S, Jariwala S, Kumar J, Muntner P, <strong>Melamed ML</strong>. Vitamin D levels and food and environmental allergies in the United States: Results from NHANES 2005-6. Journal of Allergy and Clinical Immunology 2011 May;127(5):1195-202. Epub 2011 Feb 16. PMID: 21329969<br />&nbsp;<br />Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, <strong>Melamed ML</strong>. Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011 Sept 28. (Epub)<br />&nbsp;<br />Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, <strong>Melamed ML</strong>. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES III linked mortality files. Nutrition 2012 Apr; 28(4)367-71.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney International. 2012 May;81(10):103342. Epub 2012 Feb 1. PMCID: PMC3340439<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney International. 2012 Sep;82 (6):701-9.<br />&nbsp;<br />Abramowitz MK, <strong>Melamed ML</strong>, Bauer C, Raff AC, Hostetter TH. Effects of Oral Sodium Bicarbonate in Patients with CKD. Clinical Journal of the American Society of Nephrology. 2013 Feb 7^th Epub ahead of print. 2013 May; 8(5)714-20.<br /><br /><strong>Melamed ML</strong>, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol 2013 June 27;14(1)134.<br />&nbsp;<br />Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, <strong>Melamed ML*</strong>, Atzmon G*.&nbsp; Individuals with Exceptional Longevity Manifest a Delayed Association Between Vitamin D Insufficiency and Cognitive Impairment. J Am Geriatr Soc. 2014 Jan Epub.<br />&nbsp;<br />Akchurin OM, <strong>Melamed ML</strong>, Hashim BL, Kaskel FJ, Del Rio M. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. Pediatric Transplantation. 2014 May 12 Epub. 18(5):538-48.<br />&nbsp;<br />Chen W, <strong>Melamed ML</strong>, Abramowitz MK. Serum bicarbonate and Bone Mineral Density in US Adults. Am J Kidney Dis. 2014 Aug 26 Epub. 2015 Feb;65(2):240-8.&nbsp;<br />&nbsp;<br />Sarathy H, Pramanik V, Kahn J, Abramowitz MK, Meier K, Kishore P, <strong>Melamed ML</strong>. The Effects of Short-term Vitamin D Supplementation on Glucose Metabolism in Dialysis Patients: A Systematic Review and Meta-Analysis.&nbsp; Int Urol Nephrol. 2015 Mar;47(3):537-49.&nbsp;<br />&nbsp;<br />Barry EL, Mott LA, <strong>Melamed ML,</strong> Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014. Oct 15;9(10):e108094.<br />&nbsp;<br />Calp-Inal S, Ajaimy M, <strong>Melamed ML</strong>, Savchik C, Masiakos P, Colovai A, Akalin E. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.&nbsp; Kidney Int 2015 Nov 4 (Epub ahead of print)<br />&nbsp;<br />Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, <strong>Melamed ML. </strong>Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKID) cohort. Pediatr Nephrol. 2016 Jan; 31(1):121-9.</p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-no-proof: yes;">Chen W, <strong>Melamed ML</strong>, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol. </em>2016;17(1):114.</span></p>
<p><span style="text-indent: -0.25in; font-size: 11pt; font-family: Arial, sans-serif;">Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, <strong>Melamed ML</strong>, Banerjee T, Coresh J, Hostetter TH. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. <em>J Am Soc Nephrol. </em>2017 Jan;28(1):321-31.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, <strong>Melamed ML</strong>. Vascular access placement in patients with chronic kidney disease stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.&nbsp; <em>BMC Nephrol</em>. 2017; 18(1):28.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Buttar RS, Batra J, Kreimerman J, Aleta M, <strong>Melamed ML</strong>. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med. 2017 Oct;32(10):1156-1159.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Golestaneh L Bellin E, Southern W, <strong>Melamed ML</strong>. Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2017 Dec 4;18(1):352.</span></p>
<p><strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Melamed ML</span></strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">, Chonchol M, Gutierrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018; 72(6)834-845.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Astor BC, Djamali A, Mandelbrot DA, Parajuli S, <strong>Melamed ML</strong>. The Association of 25-hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database (WisARD). Transplantation</span> <span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2019 Aug;103(8):1683-1688</span></p>
<p><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Chen W, Eisenberg R, Mowrey WB, Wylie-Rosett J, Abramowitz MK, Bushinsky DA, <strong>Melamed ML</strong>.&nbsp; Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2019 Jul 11.</span></span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Sochol KM, Johns TS, Buttar RS, Randhawa L, Sanchez E, Gal M, Lestrade K, Merzkani M, Abramowitz MK, Mossavar-Rahmani Y, </span><strong style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Melamed ML</strong><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">. The Effects of Dairy Intake on Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients 2019; 11(9):2237.</span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;"><strong>Melamed ML</strong>, Horwitz EJ, Dobre MA, Abramowitz MK, Zhang L, Lo Y, Mitch WE, Hostetter TH. The Effects of Sodium Bicarbonate in Chronic Kidney Disease Stages 3 and 4: A Randomized, Placebo-Control, Multi-Center Clinical Trial. American Journal of Kidney Diseases. 2020.</span></p>
<p>&nbsp;</p>

EMR ID

4836

Is Open Scheduling

Off

Luz E. Liriano-Ward

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/ccab2620-3cad-11ec-80f7-67047826a941.jpg

First Name

Luz

Last Name

Liriano-Ward

NPI

1801020896

Faculty ID

15436

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Kidney and Pancreas Transplantation

Research Focus

Short term and long term outcomes of deceased donor kidney transplantation. Pancreas transplant outcomes on Type 2 diabetics compared to type 1 diabetics. The use of SGLT2- inhibitor in kidney transplant recipients.&nbsp;

Elsevier Profile

EMR ID

3120

Biography

Luz Liriano-Ward, MD received her MD degree at Weill Cornell Medical College. She then completed internal medicine residency at NYU Langone Medical Center, followed by 2-years of nephrology fellowship and 1 year of transplant nephrology at Mount Sinai Hospital &ndash; Icahn School of Medicine. Dr. Liriano-Ward is a UNOS certified transplant nephrologist. Dr. Liriano-Ward is board certified by the American Board of Internal Medicine and the American Board of Nephrology. Dr. Liriano-Ward is a member of the American Society of nephrology and the American Society of Transplantation. She has special interest in medical education and acts as the director for the transplant nephrology fellowship at Montefiore Medical Center. She is also the director for the medical students&rsquo; nephrology rotation at Albert Einstein College of medicine / Montefiore Medical Center. She serves in multiple committees at the local and national level, including the Transplant Nephrology Fellowship Training Accreditation Program (TNFTAP) for the American Society of Transplantation.&nbsp;

Is Open Scheduling

Off